LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...
The FDA has approved the remote programming of cochlear implants via a telemedicine platform, freeing patients with severe to profound hearing loss from the need to visit specialized centers to get ...
Cochlear Limited, the world leader in implantable hearing solutions, has received US Food and Drug Administration approval for the first remote feature to allow follow-up programming sessions for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results